open access

Vol 83, No 2 (2012)
ARTICLES
Get Citation

The influence of patient-controlled epidural analgesia on labor progress and neonatal outcome

Andrzej Torbe, Tomasz Nikodemski, Michał Michalczyk, Maciej Żukowski, Rafał Rzepka, Sebastian Kwiatkowski, Wioletta Mikołajek-Bedner, Ryszard Czajka
Ginekol Pol 2012;83(2).

open access

Vol 83, No 2 (2012)
ARTICLES

Abstract

Abstract Aim: The aim of the study was to check the influence of patient control epidural analgesia on labor progress and neonatal outcome. Material and methods: 144 parturients were included into the clinical trial. In 73 cases patient control epidural analgesia was used and in 71 cases pethidine (meperidine) solution was given intravenously. Apgar score, umbilical artery pH, pain intensity, the time of the first, second and third stage of labor, the rate of episiotomy and uterine postpartum abrasions and the rate of caesarean sections and vaginal operative delivery were compared. Results: The time of the second stage of labor was significantly longer in the study group (40.99 vs 26.49min, p-<0,005), the neonatal outcome was comparable in both groups. There were no differences in the time of the first and the second stage of labor in primiparas and multiparas analyzed separately. Visual Analogue Score was lower in the study group (Ch2-12,48, p-0,25), especially in the subgroups of primiparas and multiparas. Conclusions: Patient control epidural analgesia does not affect the time of the first and second stage of labor, oxytocin augmentation of labor may be the reason of that. This method is a more effective way of relieving labor pain. An increase of operative delivery is not observed after patient control epidural analgesia on condition that low doses and concentrations of an-algesic drugs are used.

Abstract

Abstract Aim: The aim of the study was to check the influence of patient control epidural analgesia on labor progress and neonatal outcome. Material and methods: 144 parturients were included into the clinical trial. In 73 cases patient control epidural analgesia was used and in 71 cases pethidine (meperidine) solution was given intravenously. Apgar score, umbilical artery pH, pain intensity, the time of the first, second and third stage of labor, the rate of episiotomy and uterine postpartum abrasions and the rate of caesarean sections and vaginal operative delivery were compared. Results: The time of the second stage of labor was significantly longer in the study group (40.99 vs 26.49min, p-<0,005), the neonatal outcome was comparable in both groups. There were no differences in the time of the first and the second stage of labor in primiparas and multiparas analyzed separately. Visual Analogue Score was lower in the study group (Ch2-12,48, p-0,25), especially in the subgroups of primiparas and multiparas. Conclusions: Patient control epidural analgesia does not affect the time of the first and second stage of labor, oxytocin augmentation of labor may be the reason of that. This method is a more effective way of relieving labor pain. An increase of operative delivery is not observed after patient control epidural analgesia on condition that low doses and concentrations of an-algesic drugs are used.
Get Citation

Keywords

epidural analgesia, labor, Patient-controlled analgesia

About this article
Title

The influence of patient-controlled epidural analgesia on labor progress and neonatal outcome

Journal

Ginekologia Polska

Issue

Vol 83, No 2 (2012)

Bibliographic record

Ginekol Pol 2012;83(2).

Keywords

epidural analgesia
labor
Patient-controlled analgesia

Authors

Andrzej Torbe
Tomasz Nikodemski
Michał Michalczyk
Maciej Żukowski
Rafał Rzepka
Sebastian Kwiatkowski
Wioletta Mikołajek-Bedner
Ryszard Czajka

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl